Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...
Blog Post
November 23, 2022
This week is World Antimicrobial Awareness Week, a global campaign initiated by the World Health Organization (WHO) to improve awareness and understanding of AMR, yet only 44 percent of people have heard of AMR. We considered the portrayal of AMR in the media to determine how this might affect publi...
Blog Post
September 26, 2022
Antimicrobial resistance is a major global problem. Today, drug resistant infections kill an estimated 1.27 million people per year, and low- and middle-income countries bear the brunt of AMR-related deaths and illness. Changing how we buy antimicrobials can help solve the problem.
Blog Post
September 14, 2022
In March, the World Bank estimated that a dozen developing countries could default on their debt over the next 12 months. The warning signs are everywhere. Investors have pulled $50 billion from emerging-market bond funds this year, and the debt of nearly one-third of these countries is trading at d...
Blog Post
August 18, 2022
I’ve taken pride over the years in CGD’s success as a think-and-do tank in coming up with new “products” (outcomes of think/research) and working with officials around the world to see them adopted and implemented (outcomes of do/outreach and advocacy)). New products that change people’s lives in go...